SI 27
Alternative Names: SI-27Latest Information Update: 24 Aug 2006
At a glance
- Originator National Defense Medical College
- Class Antineoplastics
- Mechanism of Action Matrix metalloproteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 24 Aug 2006 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 10 Oct 2001 Preclinical development for Cancer in Japan (Unknown route)